Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
03/2012
03/22/2012CA2808748A1 Method for purifying pegylated erythropoietin
03/21/2012EP2431468A1 Interleukin-1 conjugates and uses thereof
03/21/2012EP2431413A1 Composite nanogranules from polymer/inorganic nanoparticles, preparation method thereof and use of the same
03/21/2012EP2431405A1 Fine particles of crystalline polyol and method of preparing same
03/21/2012EP2431403A1 Polymer conjugate of bioactive substance having hydroxy group
03/21/2012EP2431379A2 HCV inhibitors
03/21/2012EP2431366A1 New chlorine e6-folic acid conjugated compound, preparation method thereof, and pharmaceutical composition containing the same for treatment of cancer
03/21/2012EP2431055A1 Conjugates of membrane translocating agents and pharmaceutically active agents
03/21/2012EP2431054A2 Human tumor necrosis factor delta and epsilon
03/21/2012EP2431036A1 Macrocyclic lactone compounds and methods for their use
03/21/2012EP2431034A1 Adhesive patch-containing package bag and method for storing adhesive patch
03/21/2012EP2431030A1 Treatment of fungal infections
03/21/2012EP2431029A2 Method of inhibiting prostate cancer cell proliferation
03/21/2012EP2431028A2 Fast-dissolving oral film for effectively concealing unpleasant tastes
03/21/2012EP2431024A1 Method for stabilising blood plasma contents in a lyophilisate
03/21/2012EP2431020A1 Processes for the separation and purification of phosphatidylserine
03/21/2012EP2429586A1 Orally disintegrating excipient
03/21/2012EP2429574A1 Compositions and methods for treating hematologic cancers targeting the sirp - cd47 interaction
03/21/2012EP2429559A1 Treatment of pain and/or inflammation and treatment and prevention of a skin or mucosal disease and/or condition
03/21/2012EP2429510A1 Oil-in-water emulsion of mometasone and propylene glycol
03/21/2012EP2429494A2 Preparation of acetyl salicylic acid/glutamic acid complex for oral administration
03/21/2012EP2429493A1 Compositions and methods for drug delivery
03/21/2012EP2429492A2 Solid pharmaceutical preparations containing copolymers based on polyethers combined with poorly water-soluble polymers
03/21/2012EP2429491A2 Hyaluronic acid (ha) injection vehicle
03/21/2012EP2176245B1 Process for the separation of amine conjugated lipids
03/21/2012EP2151241B1 Stable solid preparation comprising 4,5-epoxymorphinan derivative
03/21/2012EP2018869B1 Licorice polyphenol preparation
03/21/2012EP2018154B1 Hydrogel suspension and manufacturing process thereof
03/21/2012EP1784169B1 Polymeric adhesive matrix with salified carboxylic groups for transdermal use
03/21/2012EP1734923B1 Zinc preservative composition and method of use
03/21/2012EP1708755B1 Transglutaminase mediated conjugation of peptides
03/21/2012EP1664321B1 Methods for expression and purification of immunotoxins
03/21/2012EP1625336B9 Use of a layer of solid fuel, method for producing such a layer and associated heating unit
03/21/2012EP1543829B1 Antiseptic bactericides and cosmetics, drugs and foods containing the antiseptic bactericides
03/21/2012EP1534248B1 Lasofoxifene tablet and its coating
03/21/2012EP1478399B1 Oral dosage form containing a pde 4 inhibitor as an active ingredient and polyvinylpyrrolidon as excipient
03/21/2012EP1427448B1 Aqueous air foam
03/21/2012CN1980699B Treatment methods utilizing albumin-binding proteins as targets
03/21/2012CN1917904B Use of organo-silicon compounds for constraining connective damaged tissues
03/21/2012CN1917861B Stabilised compositions of factor vii polypeptides
03/21/2012CN1809607B Drug delivery device comprising an active compound and method for releasing an active compound from a drug delivery device
03/21/2012CN1441770B Modified forms of pharmacologically active agents and uses therefor
03/21/2012CN1440745B Fluoxetine medicinal preparation
03/21/2012CN102388073A Nanoscale platinum compounds and methods of use thereof
03/21/2012CN102387815A Amatoxin-armed target-binding moieties for the treatment of cancer
03/21/2012CN102387792A 固体制剂 Solid preparations
03/21/2012CN102387791A Formulation for stabilizing proteins, which is free of mammalian excipients
03/21/2012CN102387790A Lyophilization cakes of proteasome inhibitors
03/21/2012CN102387787A Preparation for external application
03/21/2012CN102387784A Lyophilized recombinant vwf formulations
03/21/2012CN102382839A Anti-herpes simplex virus (HSV) active polypeptide of Tibetan Pi scorpion and application thereof
03/21/2012CN102382238A Preparation method for radiopolymerized slow-release high-polymer material
03/21/2012CN102382231A Polyacrylic resin I and preparation method thereof
03/21/2012CN102382193A Fusion protein capable of inducing and activating cancer-targeted T cells, preparation method and use thereof
03/21/2012CN102382192A Hypoallergenic recombinant immunotoxin, and preparation method and application thereof
03/21/2012CN102382172A Binding agents which inhibit myostatin
03/21/2012CN102382034A Synthetic method of N-amino-3-azabicyclo[3,3,0]octane hydrochloride
03/21/2012CN102381948A Method of stabilizing reduced coenzyme Q10
03/21/2012CN102380359A Method for preparing molecularly imprinted polymer nano-microspheres with uniform size and application thereof
03/21/2012CN102380132A Dipping process and device of protein thread
03/21/2012CN102380104A Preparation method of deoxypodophyllotoxin-hydroxypropyl beta-cyclodextrin clathrate compound
03/21/2012CN102380103A Mannose-modified thiolated chitosan quaternary ammonium salt nanoparticle, preparing method and application thereof
03/21/2012CN102380102A Method for preparing environment-responsive mesoporous silicon nanoparticles
03/21/2012CN102380096A Medicine combination containing fusion protein for suppressing angiogenesis and application
03/21/2012CN102380091A Application of interleukin-22 in curing virus hepatitis
03/21/2012CN102380007A Chinese medicinal composition for treating soft tissue sprain and bruise and preparation method and application thereof
03/21/2012CN102379956A Safer cordate houttuynia injection and preparation method thereof
03/21/2012CN102379901A Toad-cortex ultra-micro powder soft capsule and preparation method thereof
03/21/2012CN102379898A Nanometer composite skin disinfection emulsion and preparation method thereof
03/21/2012CN102379883A Pharmaceutical composition of glycerin fructose injection
03/21/2012CN102379870A Preparation method of metronidazole clotrimazole and chlorhexidine acetate vaginal effervescent tablet
03/21/2012CN102379864A Compound salvianic acid injection for treating cerebral vascular thrombosis diseases and preparation process thereof
03/21/2012CN102379861A Osmotic-pump timing sustained and controlled release capsule and preparation method thereof
03/21/2012CN102379859A Method for preparing alginate soft capsule wrapping function substrate suspension
03/21/2012CN102379858A Osmotic pump tablet capable of loading large-dose slightly-soluble medicaments and promoting absorption thereof
03/21/2012CN102379857A Levetiracetam slow release medicinal composite and preparation method thereof
03/21/2012CN102379856A Omeprazole-containing enteric coated tablets
03/21/2012CN102379854A Manidipine hydrochloride oral quick release preparation and preparation method thereof
03/21/2012CN102379853A Vidarabine monophosphate freeze-dried powder injection and preparation method thereof
03/21/2012CN102379850A Targeted administration liposome passing through mucus barriers of human bodies
03/21/2012CN102379849A Docetaxel pH-sensitive liposome and preparation method thereof
03/21/2012CN102379848A Paclitaxel immune nano liposome and preparation method and application thereof
03/21/2012CN102379847A Controlled synthesis method of nanometer polyenic taxusol liposome
03/21/2012CN102379846A Fluticasone propionate aerosol preparation with hydrofluoroalkane and polyethylene glycol as auxiliary materials
03/21/2012CN102379845A Aprepitant microemulsion for injection and preparation method thereof
03/21/2012CN102379844A Itraconazole isomer injection
03/21/2012CN102379843A Levocarnitine pharmaceutical composition for injection
03/21/2012CN102379840A Preparation and application of micromolecular hydrogel with electroresponsive characteristic
03/21/2012CN102379839A Preparation method of salicylic acid ointment
03/21/2012CN102100683B Slow-soluble external contraceptive membrane
03/21/2012CN102085178B Production process for improving stability of enoxaparin sodium injection
03/21/2012CN102078311B Method for preparing marine plant alginate polysaccharide enteric coated hard capsules
03/21/2012CN102038957B Efficient cell nucleus targeted medicine vector and application thereof to preparing antineoplastic medicines
03/21/2012CN102028668B Simvastatin osmotic pump controlled-release tablet
03/21/2012CN101935365B Method for synthesizing brain targeting head modification cyclodextrin (CD) derivative
03/21/2012CN101927989B Method for preparing ordered nest-shaped porous hydroxylapatite material
03/21/2012CN101822678B Cefamandole nafate combined drug
03/21/2012CN101810576B Puerarin self-microemulsion composition based on mixed oil and preparation method thereof
03/21/2012CN101766821B Application of polymer based on beta-cyclodextrin
03/21/2012CN101744782B Tablet containing faropenem sodium
1 ... 309 310 311 312 313 314 315 316 317 318 319 320 321 322 323 324 325 326 327 328 329 ... 1712